Determination of Rifaximin Treatment Period According to Lactulose Breath Test Values in Nonconstipated Irritable Bowel Syndrome Subjects

Lignende værker

• Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea
  af: Rezaie, Ali, et al.
  Udgivet: (2019)
• Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome
  af: Xiaojun Zhuang, et al.
  Udgivet: (2020-06-01)
• Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome
  af: Zhuang, Xiaojun, et al.
  Udgivet: (2020)
• Association between Symptoms of Irritable Bowel Syndrome and Methane and Hydrogen on Lactulose Breath Test
  af: Lee, Kang Nyeong, et al.
  Udgivet: (2013)
• Rifaximin: Irritable Bowel Syndrome
  af: Generali, Joyce A., et al.
  Udgivet: (2014)